We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...

Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the formation of its Strategic Advisory Board and the appointment of its ...

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

OliX Pharmaceuticals announced a global licensing agreement with Eli Lilly (LLY). This collaboration focuses on the development and ...

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

Thanks to impressive sales growth across multiple therapeutic areas in 2024, Eli Lilly seems to ... incretins and GLP-1s from the pharma sector, the balance of Lilly would probably be the fastest ...

Eli Lilly's Q4 revenue rose 45% YoY to $13.53B ... NOW OPEN: 200 Charter Memberships to Benzinga Trade Alerts The U.S. pharma giant reported fourth-quarter revenue of $13.53 billion, up 45% ...

On Thursday, Eli Lilly and Co (NYSE:LLY) stock is trading higher after the company released better-than-expected fourth-quarter earnings and provided 2025 guidance. The U.S. pharma giant reported ...

to the U.S. pharmaceutical company Eli Lilly. The total contract size is around 900 billion won, but the upfront payment and milestone payments related to the progress of clinical development were ...

On Thursday, Eli Lilly and Co (NYSE:LLY) stock is trading higher after the company released better-than-expected fourth-quarter earnings and provided 2025 guidance. The U.S. pharma giant reported ...